Switching from Saxenda to Wegovy
The short answer
For switching from Saxenda to Wegovy, no FDA label gives a dose conversion. The Wegovy label states a starting dose of 0.25 mg once weekly for the injection, and both labels say Saxenda and Wegovy shouldn't be used together. Self-pay Wegovy pens cost $349 a month up to 2.4 mg. Your prescriber decides your dose and timing.
Key takeaways
- Saxenda is being discontinued. Talk with your prescriber about what's next well before your supply runs short.
- No label converts Saxenda 3 mg, or any Saxenda dose, into a Wegovy dose. Your prescriber decides.
- Both labels say not to use the two together, so Wegovy replaces Saxenda. Ask your prescriber for exact dates.
- Wegovy's injection schedule takes sixteen weeks as written. Saxenda's takes five, so expect a slower pace.
- On Medicare? Wegovy is on the GLP-1 Bridge list for people who qualify. Saxenda isn't.
What the labels say about switching from Saxenda to Wegovy
The Wegovy label gives one starting dose for everyone: 0.25 mg once weekly. It gives no dose conversion from Saxenda.
The recommended starting dosage of WEGOVY injection is 0.25 mg administered subcutaneously once weekly.
The Saxenda label says using Saxenda together with other liraglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
SAXENDA contains liraglutide. Coadministration with other liraglutide-containing products or with any other glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
FDA label: Revised: 6/2026 (DailyMed version 22)
The Wegovy label says using Wegovy tablets or Wegovy injection together with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
FDA label: Revised: 6/2026 (DailyMed version 19)
Try other combinations in the switching planner. Switching is a prescriber decision.
Saxenda and Wegovy are both Novo Nordisk medicines approved for long-term weight reduction, but they contain different molecules. Saxenda is liraglutide, injected every day. Wegovy is semaglutide, injected once a week or taken as a daily tablet. Novo Nordisk has announced that Saxenda will be discontinued, with last shipments to wholesalers in late January 2027. That’s why many people on it are planning a move.
What do the Saxenda and Wegovy labels say?
Neither one describes this switch.
The Wegovy label’s switching section only covers Wegovy injection and Wegovy tablets. The Saxenda label has no section on moving to another medicine. What each label does have is a limitation of use. Saxenda’s says using it with other liraglutide-containing products, or with any other GLP-1 receptor agonist, isn’t recommended. Wegovy’s says using it with other semaglutide-containing products, or with any other GLP-1 receptor agonist, isn’t recommended.
So the labels make clear that one medicine replaces the other. They give no conversion from 3 mg of Saxenda, or from any of its step-up doses, to a Wegovy dose.
What does the Wegovy label start at?
For the injection, 0.25 mg once weekly. The dose table then moves to 0.5 mg, 1 mg and 1.7 mg, each for 4 weeks, reaching the usual maintenance dose (the dose you stay on) of 2.4 mg from week 17. Saxenda’s own schedule climbs week by week, from 0.6 mg to 3 mg in five weeks. Wegovy’s takes sixteen weeks as written, so don’t expect the same pace.
The label doesn’t say whether your time on Saxenda changes the Wegovy schedule. That’s your prescriber’s call, and this site doesn’t convert between the two.
Wegovy also comes as a tablet, starting at 1.5 mg once daily. That may appeal to you if you’d rather stop injecting. The label gives no steps for moving from Saxenda to the tablet either.
From a daily pen to a weekly one
Day to day, this is a big change. Saxenda is injected once daily, at any time of day, with a multi-dose pen. Its needles aren’t included, and you change the needle for each injection. Wegovy single-dose pens come four to a carton, and you use each one once. The label says to inject on the same day each week, at any time of day, with or without meals. Choose your injection day with your prescriber, and ask the pharmacist to show you how the new pen works.
A gap in Saxenda before the switch doesn’t create a Wegovy rule. The Saxenda label says that if more than 3 days have passed since your last dose, Saxenda is restarted at 0.6 mg daily. That instruction applies only to restarting Saxenda.
Cost before and after
Saxenda’s list price is $1,349.02, and its savings offer has been closed to new enrollees since June 30, 2023.
Wegovy has several ways to pay:
- NovoCare self-pay pens: $199 a month for up to two fills of 0.25 mg or 0.5 mg if you’re new to the offer, through December 31, 2026. Then $349 a month for doses up to 2.4 mg.
- Wegovy tablets: from $149 a month.
- If your commercial insurance covers Wegovy: as little as $25 with the savings offer.
Wegovy’s list price, $1,349.02 per package, is the same as Saxenda’s. The Wegovy cost page and Saxenda cost page have the records.
Coverage
Both medicines are approved for weight reduction. So a plan that excludes weight-loss drugs excludes both, and a plan that covered Saxenda will still ask for a new prior authorization (its approval before it pays) for Wegovy. Wegovy has one approved use that Saxenda doesn’t: lowering cardiovascular risk in adults with established cardiovascular disease and obesity or overweight. If that describes you, tell your prescriber, because it can change how a plan reviews the request.
If you’re on Medicare, Wegovy is on the GLP-1 Bridge list at a $50 copay for people who meet the criteria. Saxenda isn’t on that list.
What to bring to your prescriber
- Your current Saxenda dose, how long you’ve been on it, and how you handled each dose increase.
- A request for exact dates: your last Saxenda dose and your first Wegovy dose.
- Whether you’d prefer a weekly pen or a daily tablet.
- For patients aged 12 to 17: Wegovy injection is approved from age 12 for obesity, and the tablets are approved for adults only.
There’s more on Wegovy itself in the Wegovy guide. The switching planner covers other pairs.
Frequently asked questions
What Wegovy dose is equivalent to Saxenda 3 mg?
No label gives one. Saxenda is liraglutide, taken daily. Wegovy is semaglutide, taken weekly by injection or daily as a tablet, and its label doesn't match its doses to Saxenda's. It states a starting dose of 0.25 mg once weekly for the injection. Your prescriber decides what you're prescribed.
Can I take Saxenda and Wegovy at the same time during the switch?
Both labels say this isn't recommended. The Saxenda label says using it with any other GLP-1 receptor agonist isn't recommended, and the Wegovy label says the same about any other GLP-1 receptor agonist. The labels don't say how many days to wait between your last Saxenda dose and your first Wegovy dose, so ask your prescriber.
Is Saxenda being discontinued?
Yes. Novo Nordisk has announced that Saxenda will be discontinued, with last shipments to wholesalers in late January 2027. The Saxenda Savings Offer closed to new enrollees on June 30, 2023. If you take Saxenda, talk with your prescriber about what comes next well before supplies run short.
How much does Wegovy cost compared with Saxenda?
Saxenda's list price is $1,349.02. Wegovy pens through NovoCare are $199 a month for up to two fills of 0.25 mg or 0.5 mg if you're new to the offer, then $349 a month for doses up to 2.4 mg.
Sources (15)
- 1.FDA label (DailyMed): Saxenda prescribing information, section 1
“SAXENDA contains liraglutide. Coadministration with other liraglutide-containing products or with any other glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”
- 2.FDA label (DailyMed): Wegovy prescribing information, section 1
“Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.”
- 3.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“Inject SAXENDA subcutaneously once daily at any time of day, without regard to the timing of meals.”
- 4.FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
“Your pen is made to be used with disposable needles up to a length of 8 mm. Pen needles are not included with your Saxenda pen.”
- 5.FDA label (DailyMed): Saxenda prescribing information, section 16
“Always remove and safely discard the needle after each injection and store the SAXENDA pen without an injection needle attached. This will reduce the potential for contamination, infection, and leakage while also ensuring dosing accuracy.”
- 6.FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
“It contains 18 mg of liraglutide, and you can select doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3 mg.”
- 7.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“If more than 3 days have elapsed since the last SAXENDA dosage, reinitiate SAXENDA at 0.6 mg daily and follow the dosage escalation schedule in Table 1, to reduce the risk of gastrointestinal adverse reactions associated with reinitiation of treatment.”
- 8.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 9.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
“Your WEGOVY pen is for 1 time use only. The WEGOVY pen is for subcutaneous (under the skin) use only.”
- 10.FDA label (DailyMed): Wegovy prescribing information, section 16
“WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows:”
- 11.
- 12.
- 13.
- 14.
- 15.
